Literature DB >> 36267930

Flow-Mediated Dilation, a Marker of Endothelial Cell Dysfunction, in Patients with Pulmonary Hypertension.

Ahmad Mirdamadi1, Mohammad Shirzad2, Raana Abrishamkar2, Mohaddeseh Behjati3.   

Abstract

Background: Flow-mediated dilation (FMD) is considered a marker of endothelial cell dysfunction (ECD) and has been mostly evaluated in coronary artery disease. The role of ECD in the pathogenesis of pulmonary hypertension (PH) is not well-known. This study sought to evaluate the relationship between FMD and PH. Materials and
Methods: In this cross-sectional study, the FMD of the brachial artery was measured in 40 confirmed PH patients. Meanwhile, echocardiographic findings, the 6-minute walk test (6MWT), and serum pro-brain natriuretic peptide (pro-BNP) level were evaluated. Overall, 20 patients accomplished all evaluations, and their data were analyzed using SPSS software (version 23).
Results: There was an inverse relationship between pro-BNP and 6MWT (r<0, P<0.05). A significant direct relationship was observed between left ventricular ejection fraction and FMD (P=0.031). Right ventricular (RV) dilation was significantly correlated with pro-BNP (P=0.046). There was a significant direct correlation between RV function and FMD and a significant inverse relationship between pro-BNP and FMD (P=0.05). The independent t-test showed no relationship between FMD and syncope (P=0.75).
Conclusion: Endothelial cell function, which can be evaluated by FMD, was involved in patients with PH. The FMD and 6MWT were helpful as objective prognostic markers in PH. Furthermore, pro-BNP was a noninvasive indicator in the diagnosis of RV systolic dysfunction. Copyright
© 2021 National Research Institute of Tuberculosis and Lung Disease.

Entities:  

Keywords:  6-Minute Walk Test (6MWT); Endothelial Cell Dysfunction (ECD); Flow-Mediated Dilatation (FMD); Pulmonary Hypertension (PH)

Year:  2021        PMID: 36267930      PMCID: PMC9577205     

Source DB:  PubMed          Journal:  Tanaffos        ISSN: 1735-0344


  14 in total

1.  Variability of flow mediated dilation: consequences for clinical application.

Authors:  M L Hijmering; E S Stroes; G Pasterkamp; M Sierevogel; J D Banga; T J Rabelink
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

2.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

3.  The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.

Authors:  Thomas A Zelniker; Dörte Huscher; Anton Vonk-Noordegraaf; Ralf Ewert; Tobias J Lange; Hans Klose; Daniel Dumitrescu; Michael Halank; Matthis Held; Henning Gall; David Pittrow; Marius M Hoeper; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2018-01-24       Impact factor: 5.460

Review 4.  Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.

Authors:  Thomas Münzel; Christoph Sinning; Felix Post; Ascan Warnholtz; Eberhard Schulz
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

Review 5.  The assessment of endothelial function: from research into clinical practice.

Authors:  Andreas J Flammer; Todd Anderson; David S Celermajer; Mark A Creager; John Deanfield; Peter Ganz; Naomi M Hamburg; Thomas F Lüscher; Michael Shechter; Stefano Taddei; Joseph A Vita; Amir Lerman
Journal:  Circulation       Date:  2012-08-07       Impact factor: 29.690

6.  Association Between 6-Minute Walk Test and All-Cause Mortality, Coronary Heart Disease-Specific Mortality, and Incident Coronary Heart Disease.

Authors:  Ali Yazdanyar; Michael M Aziz; Paul L Enright; Daniel Edmundowicz; Robert Boudreau; Kim Sutton-Tyrell; Lewis Kuller; Anne B Newman
Journal:  J Aging Health       Date:  2014-04-02

7.  The WHO classification of pulmonary hypertension: A case-based imaging compendium.

Authors:  John J Ryan; Thenappan Thenappan; Nancy Luo; Thanh Ha; Amit R Patel; Stuart Rich; Stephen L Archer
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

8.  Activated platelets from diabetic rats cause endothelial dysfunction by decreasing Akt/endothelial NO synthase signaling pathway.

Authors:  Keiko Ishida; Kumiko Taguchi; Takayuki Matsumoto; Tsuneo Kobayashi
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

9.  Neurally mediated syncope: Is it really an endothelial dysfunction?

Authors:  Bahar Dehghan; Mohammad Reza Sabri; Shaghayegh Haghjooy Javanmard; Ali Reza Ahmadi; Marjan Mansourian
Journal:  Anatol J Cardiol       Date:  2015-07-29       Impact factor: 1.596

Review 10.  Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosis.

Authors:  Esin Eren; Necat Yilmaz; Ozgur Aydin
Journal:  Cholesterol       Date:  2013-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.